Royalty Pharma (NASDAQ:RPRX) posted a 26.99% decrease in earnings from Q4. Sales, however, increased by 0.18% over the previous quarter to $573.03 million. .
During Q4, Myovant Sciences (NYSE:MYOV) brought in sales totaling $24.61 million. However, earnings decreased 1.75%, resulting in a loss of $76.95 million. .
Looking at Q1, Harmony Biosciences (NASDAQ:HRMY) earned $14.53 million, a 87.33% increase from the preceding quarter. Harmony Biosciences also posted a .
SelectQuote (NYSE:SLQT) posted Q3 earnings of $54.68 million, an increase from Q2 of 55.96%. Sales dropped to $266.92 million, a 25.5% decrease between .
Jamf Holding (NASDAQ:JAMF) reported Q1 sales of $81.17 million. Earnings fell to a loss of $2.78 million, resulting in a 76.57% decrease from last quarter. .